0000899243-22-010794.txt : 20220311
0000899243-22-010794.hdr.sgml : 20220311
20220311210013
ACCESSION NUMBER: 0000899243-22-010794
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220310
FILED AS OF DATE: 20220311
DATE AS OF CHANGE: 20220311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Josephson Neil
CENTRAL INDEX KEY: 0001864141
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38068
FILM NUMBER: 22734887
MAIL ADDRESS:
STREET 1: 1385 WEST 8TH AVENUE, SUITE 540
CITY: VANCOUVER
STATE: A1
ZIP: V6H 3V9
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zymeworks Inc.
CENTRAL INDEX KEY: 0001403752
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 800 - 114 EAST 4TH AVENUE
CITY: Vancouver
STATE: A1
ZIP: V5T 1G4
BUSINESS PHONE: (604) 678-1388
MAIL ADDRESS:
STREET 1: SUITE 800 - 114 EAST 4TH AVENUE
CITY: Vancouver
STATE: A1
ZIP: V5T 1G4
FORMER COMPANY:
FORMER CONFORMED NAME: Zymeworks Inc
DATE OF NAME CHANGE: 20070620
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-10
0
0001403752
Zymeworks Inc.
ZYME
0001864141
Josephson Neil
C/O ZYMEWORKS INC.
114 EAST 4TH AVENUE, SUITE 800
VANCOUVER
A1
V5T 1G4
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Medical Officer
Common Shares
2022-03-10
4
M
0
729
0.00
A
7848
D
Common Shares
2022-03-10
4
M
0
1666
0.00
A
9514
D
Restricted Stock Unit
2022-03-10
4
M
0
729
0.00
D
Common Shares
729
730
D
Restricted Stock Unit
2022-03-10
4
M
0
1666
0.00
D
Common Shares
1666
3334
D
Represents common shares issued upon vesting of one third of the restricted stock units ("RSUs") granted on March 10, 2020.
Represents common shares issued upon vesting of one third of the RSUs granted on March 10, 2021.
Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
The RSUs were granted on March 10, 2020 and vest in three equal annual instalments beginning on March 10, 2021.
The RSUs were granted on March 10, 2021 and vest in three equal annual instalments beginning on March 10, 2022.
/s/ Daniel Dex, Attorney-in-Fact
2022-03-11